Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis
about
Helminth infections and host immune regulationSchistosomiasis-associated pulmonary hypertensionType 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP).The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest ChinaPosttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses.Resistance to liver fluke infection in the natural sheep host is correlated with a type-1 cytokine response.Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells.The immune response to schistosome antigens in formerly infected travelersFamilial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China.Acquired immune heterogeneity and its sources in human helminth infection.Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status.Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation.Human schistosome infection and allergic sensitisation.Immunopathology of schistosomiasisImmunology of human schistosomiasis: off the beaten path.Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.RGS16 attenuates pulmonary Th2/Th17 inflammatory responsesEffect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.Human genetic factors and respiratory syncytial virus disease severity.Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γRegulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica.Familial aggregation of human helminth infection in the Poyang lake area of China with a focus on genetic susceptibility to schistosomiasis japonica and associated markers of disease.Diversity and dialogue in immunity to helminths.Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
P2860
Q26829956-DC3849FA-502F-4616-8B21-D6D82BDA814FQ27006491-68ADB909-F228-404F-8344-F10E09E8E5D1Q33397364-0C85150E-0BE1-49BD-9CAD-8096FD553484Q33587278-85B01B30-A622-4E81-9082-3ACB9A7B6E84Q33596079-BE831F1A-02F0-4B95-9627-F1BDE110AF2FQ33944725-5A35AC55-3C67-494B-BEF0-416F3DCFA85EQ34123969-001822DC-6162-4133-A22D-56D139E9CB74Q34422358-0739BAC6-FC7B-43EB-96B8-8C22D83C0DD4Q34424901-EFDFD916-E465-47B0-90A1-E796FBB4B995Q34495730-A2A6A525-D859-4852-A0B8-D240233A9210Q34551221-BDBED31A-2E0F-4313-8881-4096932438E7Q34626126-9EB149B3-A3B7-4349-AE26-0DA0D6954DA8Q34740114-9DEDD7BD-F57D-4E50-91EB-557BFF9F062BQ36210573-EACA6714-6992-4DE2-B3A3-2A11B51043BAQ36220509-91FEC14F-9B87-47BD-A3BD-9E26B4A46333Q36247378-7C3AE227-9011-4469-BEA4-358B33D472D4Q36330066-B2257279-A685-406B-AA51-712B6448E01BQ36466384-0D357461-D977-4BA8-9D36-2A1A9EF1B8CCQ36803942-F3F9F445-AAF6-48EC-AB6B-CCAD2D25CFB4Q36943137-D4C15885-67B9-4911-9966-3F12124E64A3Q37026406-C8E3F671-8D45-4354-B173-C0F83BB719D1Q37365765-3BB1F96B-97D6-43A6-AAB5-0C0295083AE8Q37375960-909C2B87-9BD8-48D0-A321-B39EB2FAD189Q37503791-46287E59-0867-4B54-A831-6ABC59D7D484Q37879452-53067B60-EE06-4C73-8184-0C02E876250BQ39551535-3E583590-CE6B-49F4-9BC8-B1746F629F81
P2860
Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@ast
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@en
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@nl
type
label
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@ast
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@en
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@nl
prefLabel
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@ast
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@en
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@nl
P2093
P2860
P50
P1476
Interleukin-13 in the skin and ...... ction in human schistosomiasis
@en
P2093
Alain Dessein
Bourema Kouriba
Carole Eboumbou
Helia Dessein
Laurent Argiro
Nasr-Eldin M A Elwali
Virmondes Rodrigues
Yuesheng Li
P2860
P304
P356
10.1111/J.0105-2896.2004.00195.X
P407
P577
2004-10-01T00:00:00Z